Composition, form of production and packaging
A syrup in the form of a liquid of red color with the smell of raspberry and sweet taste.
5 ml
salbutamol (in the form of sulfate) 1 mg
bromohexine hydrochloride 2 mg
guaifenesin 50 mg
menthol 500 Ојg
Auxiliary substances: sucrose, citric acid monohydrate, sodium edetate, sodium benzoate, potassium sorbate, propylene glycol, glycerol, sorbitol solution 70%, menthol, raspberry flavor, purified water, 4C reddish dye.
100 ml - bottles of dark glass (1) complete with a measuring cup - packs of cardboard.
200 ml - bottles of dark glass (1) complete with measuring cup - packs cardboard.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2016.
PHARMACHOLOGIC EFFECT
Pharmacodynamics
A combination drug consisting of ingredients used for the symptomatic treatment of cough for various pulmonary diseases. It has bronchodilator, mucolytic and expectorant action.
Salbutamol has a bronchodilator effect by selective action on the beta-2-adrenergic bronchial receptors.
Bromgexin dilutes sputum, increases its volume. Mucolytic action is due to the ability to depolymerise and dilute mucoproteins and mucopolysaccharide fibers.
Guaifenesin has an expectorant effect. Reduces adhesiveness, surface tension of sputum, which improves its departure.
Menthol has a weak antiseptic properties has a calming effect and reduces irritation of the mucous membrane of the respiratory tract.
INDICATIONS
Acute and chronic bronchopulmonary diseases, accompanied by difficulty in sputum discharge (bronchial asthma, tracheobronchitis, obstructive bronchitis, pneumonia, emphysema, pneumoconiosis, etc.).
DOSING MODE
Preparation Kashnol appoint adults and children over 12 years of 10 ml (2 teaspoons) 3 times a day,
children under 6 years - 5 ml (1 teaspoon) 3 times a day,
children from 6 to 12 years - 5-10 ml (1-2 teaspoons) 3 times a day.
Between the use of regular doses of the drug requires a break of at least 6 hours.
SIDE EFFECT
Sometimes there is headache, dizziness, increased nervous excitability, sleep disturbance, drowsiness, tremor, convulsions, nausea, vomiting, diarrhea, peptic ulcer and palpitations, palpitations, possibly urine staining pink, allergic reactions (rash, urticaria ), lowering of arterial pressure, collapse.
CONTRAINDICATIONS
Hypersensitivity to the components of the drug; pregnancy, lactation, tachycardia, myocarditis, heart defects, decompensated diabetes mellitus, thyrotoxicosis, glaucoma, hepatic or renal insufficiency, gastric and duodenal ulcer in the acute stage, sucrose / isomaltose deficiency, fructose intolerance, glucose-galactose malabsorption (i.e. The preparation contains sucrose and sorbitol).
Edit Warnings
The drug Kashnol should be used carefully in patients with diabetes mellitus, hypertension, peptic ulcer of the stomach and duodenal ulcer in remission. If you need to treat Kashnol during lactation, breastfeeding should be discontinued.
PREGNANCY AND LACTATION
The drug is contraindicated for use in pregnancy.
If you need to treat Kashnol during lactation, breastfeeding should be discontinued.
APPLICATION FOR FUNCTIONS OF THE LIVER
Contraindication: renal insufficiency
APPLICATION FOR VIOLATIONS OF THE FUNCTION OF KIDNEYS
Contraindication: liver failure
APPLICATION FOR CHILDREN
Contraindication: children under 3 years.
OVERDOSE
No cases of overdose have been reported. Possible enhancement of the above side effects.
Treatment is symptomatic.
DRUG INTERACTION
Other beta-2-adrenomimetic agents and theophylline increase the effect of salbutamol and increase the likelihood of side effects.
Cough is not prescribed concomitantly with drugs containing codeine and other antitussive agents, as this makes it difficult to move away diluted sputum.
Included in the drug Kashnol, bromhexine promotes the penetration of antibiotics (erythromycin, cephalexin, oxytetracycline) into the lung tissue.
It is not recommended to use Kashnol at the same time as nonselective beta-adrenoreceptor blockers, such as propranolol.
Included in the composition of the drug Kashnol salbutamol is not recommended for patients who receive MAO inhibitors.
Diuretics and preparations of glucocorticosteroids increase the hypokalemic effect of salbutamol.
Alkaline drink is not recommended at the same time as Kashnol.
TERMS OF RELEASE FROM PHARMACY
The drug is released on prescription.
TERMS AND CONDITIONS OF STORAGE
The drug should be stored at a temperature of no higher than 25 В° C in a place protected from light and out of reach of children. Do not use after the expiration date.Shelf life - 3 years.
